Cited by 862Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment ResearchIntensive Care Unit Cognitive Disorders

Impact of Anticholinergics on the Aging Brain: A Review and Practical Application

Abstract

Objective: in an effort to enhance medication prescribing for older adults and reduce the burden of cognitive impairment, this paper reviews the literature regarding the negative impact of anticholinergics on cognitive function and provides clinicians with a practical guidance for anticholinergic use in older adults. Methods: a Medline search identified studies evaluating the use of anticholinergics and the relationship between anticholinergics and cognitive impairment. Results: prescribing anticholinergics for older adults leads to acute cognitive impairment and, possibly, chronic cognitive deficits. Assessing anticholinergic burden with a simple scale may represent a useful noninvasive tool to optimize geriatric pharmacotherapy. Conclusion: more studies are needed to validate the Anticholinergic Cognitive Burden scale and establish therapeutic guidelines in the presence of cognitive anticholinergic adverse effects.

Integrity signals

Registry

Crossref · 10.2217/1745509x.4.3.311

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Serum anticholinergic activity measured by a receptor bioassay does not correlate well with effects on cognition.

    “Serum anticholinergic activity measured by a receptor bioassay does not correlate well with effects on cognition,16 28”
  • The study also included additional drugs from the Beers 2015 updated list of strong anticholinergic drugs, the Anticholinergic Cognitive Burden scale, a systematic review, and the British National Formulary.

    “We also included additional drugs in the Beers 2015 updated list of strong anticholinergic drugs,15 drugs listed as having a high anticholinergic burden in the Anticholinergic Cognitive Burden scale,16 or identified as high-potency anticholinergics in a systematic review,17 and some further drugs identified as having substantial anticholinergic properties in the British National Formulary”

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. Vangala VR , TuethMJ: Chronic anticholinergic toxicity: identification and management in older patients.Geriatrics358, 36–37(2002).
  2. 10.1046/j.1532-5415.2002.50208.x · DOI
  3. 10.1097/00019442-199802000-00005 · DOI
  4. 10.1093/geronj/38.1.31 · DOI
  5. 10.1001/archpsyc.60.2.198 · DOI
  6. Tune LE : Anticholinergic effects of medication in elderly patients.J. Clin. Psychiatry62(Suppl. 21), 11–14(2001).
  7. 10.1001/archinte.1995.00430050035004 · DOI
  8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association Washington DC USA (1994).
  9. Boustani M ButtarA: Delirium. In: Primary Care Geriatrics a Case-Based Approach (5th Edition). Ham RJ Sloane PD Warshaw GA Bernard MA Flaherty E (Eds). Chapter 15 210–218(2007). · DOI
  10. Boustani M HamRJ: Alzheimer disease and other dementias. In: Primary Care Geriatrics a Case-Based Approach (5th Edition). Ham RJ Sloane PD Warshaw GA Bernard MA Flaherty E (Eds). Chapter 16 219–236(2007). · DOI
  11. 10.2147/cia.s1802 · DOI
  12. 10.7326/0003-4819-138-11-200306030-00015 · DOI
  13. 10.1016/S0140-6736(05)67889-0 · DOI
  14. 10.1046/j.1532-5415.5157.x · DOI
  15. 10.1124/jpet.102.041616 · DOI · Paper page
  16. 10.2174/092986706777935203 · DOI
  17. 10.1176/ajp.157.1.4 · DOI
  18. 10.1073/pnas.012467899 · DOI
  19. 10.1007/BF02244414 · DOI · Paper page
  20. 10.1007/BF02245172 · DOI · Paper page
  21. 10.1016/0197-4580(80)90022-6 · DOI
  22. 10.1097/00019442-200506000-00013 · DOI
  23. 10.1345/aph.18273 · DOI
  24. 10.1002/ana.10639 · DOI · Paper page
  25. 10.1592/phco.2005.25.11.1592 · DOI
  26. 10.1176/jnp.3.3.314 · DOI
  27. 10.1176/ajp.149.10.1393 · DOI
  28. 10.1111/j.1532-5415.2005.00543.x · DOI
  29. Ancellin ML , ArteroS, PortetF, DupuyAM, TouchonJ, RithieK: Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.Br. Med. J.332(7539), 455–459(2006).
  30. 10.1177/0091270006292126 · DOI
  31. 10.1001/archpsyc.1980.01780160063007 · DOI
  32. 10.2165/00002512-199915010-00002 · DOI
  33. 10.1111/j.1532-5415.1995.tb06113.x · DOI
  34. 10.1001/archinte.161.8.1099 · DOI
  35. 10.1001/archinte.163.22.2716 · DOI · Paper page
  36. 10.2165/00002512-199303040-00004 · DOI
  37. 10.1097/00019442-200303000-00011 · DOI
  38. 10.1007/BF00433493 · DOI
  39. Boustani MA , LimbilT, CampbellN, Fox C, Maidment I: Anticholinergic burden: measurement and impact. J. Am. Geriatr. Soc.55, S52 (2007).
  40. 10.1097/01.JGP.0000224619.87681.71 · DOI
  41. 10.1345/aph.1G318 · DOI
  42. 10.1176/appi.ajp.162.3.627 · DOI
  43. 10.1001/archinternmed.2007.106 · DOI · Paper page
  44. Boustani M Peterson B Hanson L Harris R Krasnov C: Screening for dementia. Systematic evidence review. Agency for Healthcare Research and Quality Rockville MD USA (2003). www.ahrq.gov/clinic/uspstfix.htm · DOI

Cited by

Sorted by citations

Authors
Boustani, M., Campbell, N., Munger, S., Maidment, I., & Fox, C.
Affiliations
  • Regenstrief Institute (US)
  • Sidney & Lois Eskenazi Hospital (US)
  • St Martin's Hospital (GB)
  • Shepway Caste Department of Old Age Psychiatry, Fokestone Health Centre,15–25 Dover Road, Folkestone, Kent, CT2 1JY, UK.
Venue
Aging Health
Published
2008-06
Volume
4
Issue
3
Pages
311-320
ISSN
  • 1745-509X (ISSN-L)
  • 1745-5103
OpenAlex
W2095755860
Cited by
862
References
1
Citations by year
2026: 93 · 2025: 90 · 2024: 92 · 2023: 70 · 2022: 61 · 2021: 69 · 2020: 94 · 2019: 61 · 2018: 41 · 2017: 42 · 2016: 36 · 2015: 36 · 2014: 28 · 2013: 20 · 2012: 13
FWCI
4.19
Type
journal article
Language
en
Open access
closed
Locations
  • Aging Health (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
Keywords
anticholinergic agents, cognitive impairment, older adults, anticholinergic burden, Anticholinergic Cognitive Burden Scale, geriatric pharmacotherapy, drug prescribing, cognitive decline, adverse drug reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review